Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,221 to 1,240 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Genomic Instability-Related Long Noncoding RNA Signature for Predicting Hepatocellular Carcinoma Prognosis. | J Oncol | 2022 | 36072979 | PubTator, text mining | PubMed |
| Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review. | Investig Clin Urol | 2022 | 36067994 | PubTator, text mining | PubMed |
| Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma. | Clin Cancer Res | 2022 | 36067339 | PubTator, text mining | PubMed |
| Identification of a prognostic model based on costimulatory molecule-related subtypes and characterization of tumor microenvironment infiltration in acute myeloid leukemia. | Front Genet | 2022 | 36061194 | PubTator, text mining | PubMed |
| Understanding the function of regulatory DNA interactions in the interpretation of non-coding GWAS variants. | Front Cell Dev Biol | 2022 | 36060805 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer. | Front Cell Dev Biol | 2022 | 36060798 | PubTator, text mining | PubMed |
| Identification of endoplasmic reticulum stress-associated genes and subtypes for prediction of Alzheimer's disease based on interpretable machine learning. | Front Pharmacol | 2022 | 36059957 | PubTator, text mining | PubMed |
| Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer. | BMC Med Genomics | 2022 | 36056349 | PubTator, text mining | PubMed |
| A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma. | Clin Immunol | 2022 | 36055572 | PubTator, text mining | PubMed |
| Development of a GalNAc-Tyrosine-Specific Monoclonal Antibody and Detection of Tyrosine O-GalNAcylation in Numerous Human Tissues and Cell Lines. | J Am Chem Soc | 2022 | 36054098 | PubTator, text mining | PubMed |
| Advanced Cell Therapies for Glioblastoma. | Front Immunol | 2022 | 36052072 | PubTator, text mining | PubMed |
| Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma. | Front Genet | 2022 | 36051690 | PubTator, text mining | PubMed |
| Obesity: a perfect storm for carcinogenesis. | Cancer Metastasis Rev | 2022 | 36038791 | PubTator, text mining | PubMed |
| Inflammatory aging clock: A cancer clock to characterize the patients' subtypes and predict the overall survival in glioblastoma. | Front Genet | 2022 | 36035122 | PubTator, text mining | PubMed |
| mRNA vaccines in the prevention and treatment of diseases. | MedComm (2020) | 2022 | 36033422 | PubTator, text mining | PubMed |
| A promising antitumor method: Targeting CSC with immune cells modified with CAR. | Front Immunol | 2022 | 36032145 | PubTator, text mining | PubMed |
| Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects. | Vaccines (Basel) | 2022 | 36016159 | PubTator, text mining | PubMed |
| Application of mRNA Technology in Cancer Therapeutics. | Vaccines (Basel) | 2022 | 36016150 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches. | Pharmaceutics | 2022 | 36015348 | PubTator, text mining | PubMed |
| Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable. | Pharmaceutics | 2022 | 36015322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=62